A PI3K gene expression signature enrichment analysis of ER+ breast cancer compared the two luminal breast cancer subtypes and found that the luminal B subtype has higher PI3K activity, which may make it less effective for antiestrogen therapy [42,51]. This evidence concerns the gene PIK3CB and breast carcinoma.